NCT00354887 - Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Gastrointestinal Cancer

Interventions

DRUG

Capecitabine

Oral capecitabine 750 mg/m\^2 twice daily (total daily dose 1500 mg/m\^2) on Days 1-14 in 21 Day Cycle.

DRUG

Oxaliplatin

130 mg/m\^2 by vein Day 1 over 2 hours in 21 Day Cycle

Trial Locations (1)

U.T. M.D. Anderson Cancer Center, Houston